Mode
Text Size
Log in / Sign up
Phase 2 N=41 Randomized Quadruple-blind Treatment

Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Chronic Aphasia

Aphasia

Enrolled (actual)
41
Serious AEs
4.9%
Results posted
Sep 2025
Primary outcome: Primary: Change in WAB-AQ — 3.0; 2.8 score on a scale — p=<.05

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Active TMS (Device); Sham TMS (Device); CILT (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
H. Branch Coslett
Primary completion
Aug 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in WAB-AQ
3.0; 2.8 <.05 sig
SECONDARY
Change in Percentage of Items Correct on the PNT
3.4; 3.4 <.05 sig

Summary

Transcranial Magnetic Stimulation (TMS) has been demonstrated to improve language function in subjects with chronic aphasia in a number of small studies, many of which did not include a control group. Although the treatment appears promising, data to date do not permit an adequate assessment of the utility of the technique. The investigators propose to study the effects of TMS combined with Constraint Induced Language Therapy (CILT) in 75 subjects with chronic aphasia. Subjects will be randomized in a 2:1 ratio to TMS with CILT or sham TMS with CILT. One Hz TMS at 90% motor threshold will be delivered to the right inferior frontal gyrus for 20 minutes in 10 sessions over 2 weeks; language therapy will be provided for one hour immediately after the conclusion of each session of TMS. Change from baseline in the Western Aphasia Battery Aphasia Quotient at 6 months after the end of TMS treatment will serve as the primary outcome measure.

Eligibility Criteria

Inclusion Criteria

  • Clinical evidence and MRI or CT verification of a single left hemisphere stroke with moderate to severe aphasia.
  • Suffered their stroke at least 6 months prior to their testing
  • Must be able to understand the nature of the study, and give informed consent

Exclusion Criteria

  • Multiple strokes (excluding small lacunar strokes) as defined by brain imaging
  • History of substance abuse
  • Previous head trauma with loss of consciousness for more than 5 minutes
  • Psychiatric illness (We note that subjects will be assessed with the 15-item Geriatric Depression scale. Because depression is very difficult to evaluate in aphasic subjects, potential subjects will not be excluded on the basis of the depression score)
  • Chronic exposure to medications that might be expected to have lasting consequences for the central nervous system (e.g. haloperidol, dopaminergics)
  • History of or neuropsychological findings suggestive of dementia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03651700). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search